期刊文献+

终末期肝病模型评分系统对慢性重型肝炎不同血浆量的血浆置换的疗效及预后分析 被引量:2

Plasma exchange treatment using MELD scoring system and different capacity analyzes the curative effect and prognosis of fulminant hepatitis in Chinese patients
下载PDF
导出
摘要 目的应用终末期肝病模型(MELD)评分系统预测血浆置换(PE)治疗重型肝炎疗效及预后。方法172例重型肝炎患者随机分为A(2000mL)组、B(3000mL)两组,并设对照组(未PE治疗)。应用终末期肝病模型(MELD)评分系统判断患者(PE)治疗的病死率和治疗前后的临床生化指标进行比较,探讨病情与预后的关系。结果MELD分值在30~39患者PE后两组总胆红素(TBIL)、凝血酶原时间国际标准化比值(INR)、血肌酐(Cr)均明显低于治疗前的水平,差异有统计学意义(P〈0.01)。病死率:A组为48.28%,B组为46.43%,均明显低于对照组(83.33%),差异有统计学意义(P〈0.01)。MELD分≥40的患者PE后的TBIL、INR也明显低于治疗前的水平,差异有统计学意义(P〈0.01),但血清Cr差异无统计学意义(P〉0.05)。病死率A、B组分别为88.89%、82.14%,与对照组96.67%相比,差异无统计学意义(P〉0.05)。结论不同血浆量的血浆置换均可改善肝脏功能,尽早PE治疗可提高患者存活率。 Objective To study the prognosis of patients with fulminant hepatitis after using different capacity in PE treatment plasma exchange treatment using model for end-stage liver disease (MELD)scoring system. Methods One hundred and seventy-two patients with heavy hepatitis were divided into two group, and the relation between the illness state and the prognosis was discussed after comparative study on patients' mortality rates by stages and the clinical biochemical indexes before and after the treatment. Results TBIL, INR and Cr levels of MELD score from 30 and 40 sufferer were evidently lower than the levels before the PE treatment and the differences had statistic meaning(P 〈0.01 ). The patients' mortality rates were 48. 28% in group A and 46. 43% in group B, which were lower than the rate 83.33% in the comparison group, and the differences had statistic meaning (P 〈0. 01 ). But the MELD scores higher than 40 of effect on serum Cr had no statistic meaning (P 〉 0.05) , which may be related to the lack of evidence on the improvement of kidney function resulting from the solitary PE treatment. The mortality rates in the groups with PE treatment were 88.89% in group A and 82.14% in group B respectively, comparing to the rate 96.67% in the comparison group, and the differences on the mortality rates had no statistic meaning (P 〉 0.05). Conclusion Plasma exchange treatment using different capacity can improve liver function.
出处 《胃肠病学和肝病学杂志》 CAS 2008年第10期846-848,共3页 Chinese Journal of Gastroenterology and Hepatology
关键词 重型肝炎 血浆置换 疗效 终末期肝病模型 Fulminant hepatitis Plasma exchange Efficacy Model for end-stage liver disease
  • 相关文献

参考文献8

二级参考文献16

  • 1Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology, 2001, 33: 464-470.
  • 2Forman LM, Lucey MR. Predicting the prognosis of chronic liver disease: an evolution from child to MELD. Mayo End-stage Liver Disease. Hepatology, 2001, 33: 473-475.
  • 3Botta F, Giannini E, Romagnoli P, et al. MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function: a European study. Gut, 2003, 52: 134-139.
  • 4Mas A,Rodeg J.Fulminant hepatitis failure.Lancet,1997,349:1081-1085.
  • 5Forman LM,Lucey MR.Predicting the prognosis of chronic liver disease:an evolution from Child to MELD.Hepatology,2001,33:473-475.
  • 6Malinchoc M,Kamath PS,Gordon FD,et al.A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.Hepatology,2000,31:864-871.
  • 7Hanley JA,McNeil BJ.The meaning and use of the area under a receiver operating characteristic(ROC) curve.Radiology,1982,143:29-36.
  • 8Botta F,Giannini E,Romagnoli P,et al.MELD scoring system is useful for predicting prognosis in patients with liver cirrhosis and is correlated with residual liver function:a European study.Gut,2003,52:134-139.
  • 9Acharya SK,Dasarathy S,Kumer TL,et al.Fulminant hepatitis in a tropical population:clinical course,cause,and early predictors of outcome.Hepatology,1996,23:1448-1455.
  • 10Angermayr B,Cejna M,Karnel F,et al.Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt.Gut,2003,52:879-885.

共引文献14067

同被引文献11

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部